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calcific plaques. In addition, NV was the most powerful independent predictor for disrup- 
tion, suggesting a cause-effect relationship between NV and progression to disruption in 
high-risk atherosclerotic plaques. 
prognostic role of cTnT and cTnl in patients with ACS or UA by means of a meta-analy- 
sis. 
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Methods: 45 studies from 1990 to 2000 were independently reviewed by 2 investigators; 
20 studies met the prespecified eligibility criteria. Odd ratio (OR) values were calculated 
for short-term (30 days) and long-term (25 months) outcomes in ACS patients, as well as 
In the subgroup of patients with UA. The primary outcome measure was the composite of 
death or nonfatal myccardial infarction. 
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Results: A total of 7,443 patients were included; 4,909 patients wereevaluated with a 
cTnT test and 2,534 with a cTnl test. Predictive values of cTnT and cTnl differed mini- 
mally according to a studied population and the follow-up period (Table). 
Conclusions: In patients with ACS, cTnT and cTnl elevation predicted similar odds of 
death or nonfatal myccardial infarction for both short- and long-term follow-up. In the sub- 
group of pabents with UA. cTnT or cTnl elevation predicted higher relative risk of short- 
term events when compared to the ACS cohort. 
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A Combination of Pro-BNP Och Troponin Tat Baseline 
Provide the Best Prediction of Risk of Death and 
Myocardial Infarction Early After Acute Coronary 
Syndrome 
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Disease: Focus on the Four Conventional Risk Factors 
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Background: It is commonly believed that nwre than 50% of patients with coronary 
heart disease [CHD] lack any of the conventional risk factors [RF] (cigarette smoking, 
diabetes, hyperlipidemia, hypertension). This implies that other factors play a significant 
role in CHD and has led to interest in non-traditional RF and genetic causes of CHD. We 
tested the accuracy of this contention. Methods: We compiled data from 14 clinical trials 
Involving 122,458 patients with a wide spectrum of CHD. The prevalence of each con- 
ventional RF was calculated and patients were categorized according to their number of 
RF. Results: Patients without any of the four conventional RF constituted 15.4% of 
women and 19.4% of men. In men ~55 years and women ~65 years and most patients 
presenting with either unstable angina or for percutaneous Intervention, the prevalence 
of the conventional RF was even higher, with only IO-15% of patients lacking any of the 
four conventional RF. This pattern was Independent of gender, geographic region, and 
trial entry criteria. Premature CHD was related to cigarette smoking In both genders and 
diabetes I” women. Conclusions: In direct contrast with conventional thinking, 80.90% 
of patients with CHD have conventional RF. Although research into nontraditional RF 
and genetic causes of CHD is important, clinical medicine, public health policies, and 
research efforts should place significant emphasis on the four conventional RF and the 
lifestyle behawors that cause them to reduce the epidemic of CHD. 
Background: Elevated levels of Troponln T (TnT) and Brain Natriuretic peptide (BNP) in 
the acute stage acute coronary syndromes (ACS) has individually been shown to associ- 
ated with an increased risk of subsequent clinical events. 
Methods: The GUSTO IV ACS trial, evaluating the efficacy of abciximab as the primary 
medical treatment in ACS without early revascularization, included 7800 patients with 
chest pain withln 24 hours and elther ST-segment depression or elevation of troponin at 
entry. Levels of TnT and pro-BNP in blood samples obtained at randomization were ana- 
lyzed in 7115 and 6083 patients respectively. The results were related to clinical events 
at 30.days follow-up. 
Results: 
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In a multiple logistic regression analysis Including a large number of known clinical risk 
factors, TnT and pro-BNP were significant independent predictors of 30.day mortality 
and the combined endpoint. 
Conclusion: In a large cohort of patients with suspected ACS without ST-elevation lev- 
els of TnT and and pro-BNP provided independent prognostic Information. The combina- 
tlon of the markers provided an even stronger prediction of cllnical events in the early 
phase, 
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Background: An elevation of cardiac troponin T (cTnT) or troponin I (cTnl) is predictive 
of adverse outcomes in patients with non-ST elevation acute coronary syndromes (ACS), 
defined as unstable angma (UA) or non-Q-wave myocardial infarction. However, differ- 
ences in the predictive value between cTnT and cTnl may exist. We Investigated the 
Kim A. Eaale Michael J. Lim, Andrzej Bud& Omar H. Dabbous. Karen Pieper, Shaun G 
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The University and The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom 
Background: Risk prediction models have been developed to assist clirwians in esti- 
mating risk of untoward outcomes in patients wth unstable angina (UA), non-ST seg- 
ment deviation myocardial infarction (NSTEMI), or ST segment elevation myocardial 
infarction (STEMI). We previously have devoloped a model for mortality prediction in 
patients with acute coronary syndromes (ACS). However, no single model exists that can 
predict risk of death or recurrent Ml (rMI) in all pabents presenting with (ACS). 
Methods: Using the GRACE database, we developed a multivariate logisbc regression 
model to predict the combined endpoint of death or rMI !n 18116 patients (2300 patients 
